Max Healthcare Institute Limited (NSE:MAXHEALTH)
India · Delayed Price · Currency is INR | Market Cap | 1.04T -13.9% |
| Revenue (ttm) | 83.73B +19.1% |
| Net Income | 14.42B +34.1% |
| EPS | 14.76 +34.1% |
| Shares Out | n/a |
| PE Ratio | 72.20 |
| Forward PE | 54.52 |
| Dividend | 2.00 (0.19%) |
| Ex-Dividend Date | Jul 3, 2026 |
| Volume | 2,891,935 |
| Open | 1,065.40 |
| Previous Close | 1,069.00 |
| Day's Range | 1,034.70 - 1,067.40 |
| 52-Week Range | 903.00 - 1,301.70 |
| Beta | 0.13 |
| Analysts | Buy |
| Price Target | 1,172.62 (+12.82%) |
| Earnings Date | Aug 13, 2026 |
About Max Healthcare Institute
Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including cardiac sciences, orthopedics, oncology, renal sciences, neurosciences, minimal access and general surgery, pulmonology, obstetrics, bone marrow transplant, bariatric/weight loss surgery, gynecology, minimal access/laparoscopic surgery, eye care/ophthalmology, robotic surgery, paediatrics, nephrology, liver and biliary sciences, gastroenterology and GI surgery, internal medicine, organ transplants, and plastic... [Read more]
Financial Performance
In fiscal year 2026, Max Healthcare Institute's revenue was 83.73 billion, an increase of 19.14% compared to the previous year's 70.28 billion. Earnings were 14.42 billion, an increase of 34.07%.
Financial StatementsAnalyst Summary
According to 27 analysts, the average rating for MAXHEALTH stock is "Buy." The 12-month stock price target is ₹1,173, which is an increase of 12.82% from the latest price.
News
Top stocks to buy or sell today: Stock recommendations for July 29, 2026 - check list
Stock market recommendations: United Breweries, and Max Healthcare are the top stocks to buy recommended by Mehul Kothari, DVP - Technical Research at Anand Rathi Shares for July 29, 2026. Adani Enter...
Max Healthcare reports ₹8,373.45 crore turnover for FY 2025-26
Max Healthcare Institute has reported a turnover of ₹8,373.45 crore for the financial year 2025-26, according to its Business Responsibility and Sustainability Report (BRSR). The report highlights the...
Max Healthcare launches second 100-day campaign to prevent dividend transfer to IEPF
Max Healthcare Institute has announced its participation in the 'Saksham Niveshak' campaign, a 100-day initiative directed by the Investor Education and Protection Fund Authority (IEPFA) under the Min...
Max Healthcare receives no-objection for reclassification of Radiant Life Care Foundation
Max Healthcare Institute has received no-objection letters from the National Stock Exchange of India (NSE) and BSE Limited for the reclassification of Radiant Life Care Foundation from the 'Promoter G...
Max Healthcare acquires 100% Class A equity in Yerawada Properties
Max Healthcare Institute has announced the acquisition of 100% of the Class A equity shares in Yerawada Properties Private Limited (YPPL), Pune. This acquisition represents 100% of the voting rights…
Max Healthcare faces ₹32.81 lakh penalty from Income Tax Department
Max Healthcare Institute has been hit with a penalty of ₹32,81,528 by the Assessment Unit of the Income Tax Department. The penalty was imposed for transactions related to the company's…
Max Healthcare faces ₹11.33 lakh penalty from Income Tax Department
Max Healthcare Institute has been penalised ₹11,33,130 by the Income Tax Department. The penalty stems from transactions with an employee and a vendor, which were adjusted through journal entries and…
Max Healthcare shares surge over 5% today: Details here
Max Healthcare shares gained more than 5% in Thursday's trading session, with strong buying interest lifting the stock to an intraday high of ₹1,139.80. As of 11:30 AM, the stock…
Max Healthcare share price jumps over 4% after Citi reiterates Buy rating, maintains Rs 1,240 target
Max Healthcare shares climbed more than 4% in Thursday's trading session after global brokerage Citi reiterated its Buy rating on the hospital operator and maintained a target price of ₹1,240…
Stocks to watch today on brokerages today, June 18: Vedanta, Tata Motors, Titan, Max Healthcare, Shyam Metalics in focus
Several stocks are likely to remain in focus on June 18 after fresh brokerage reports and sector outlook updates. Vedanta, Tata Motors, Titan, Max Healthcare, Shyam Metalics, Tata Communications, Asia...
Max Healthcare share price in focus after Citi maintains Buy rating; Sees 20% EBITDA CAGR through FY30
Max Healthcare shares are likely to remain in focus after global brokerage Citi reiterated its Buy rating on the hospital operator and maintained a target price of ₹1,240 per share.…
Max Healthcare shares in focus as Jefferies remains bullish; sees strong bed expansion-led growth ahead
Max Healthcare shares are likely to remain in focus after Jefferies reiterated its Buy rating on the hospital operator and maintained a target price of Rs 1,230 per share, expressing…
Max Healthcare seeks re-classification of Radiant Life Care Hospital Foundation to public category
Max Healthcare Institute has submitted an application to the National Stock Exchange of India Limited and BSE Limited to re-classify Radiant Life Care Hospital Foundation from the 'Promoter Group' to…
Max Healthcare to set up 712-bed hosp for ₹1,400 cr along Shaheed Path
Max Healthcare plans a 712-bed super-speciality hospital on Shaheed Path, Lucknow, investing Rs 1,400 crore; second facility to open by 2030.
Max Healthcare receives favourable CCI orders, closing abuse of dominance case
Max Healthcare Institute has announced that the Competition Commission of India (CCI) has issued separate orders favouring its network hospitals, concluding that no case of abuse of dominant position ...
Max Healthcare Institute Transcript: Q4 25/26
Revenue and EBITDA grew strongly year-over-year, supported by capacity expansion and digital initiatives. Oncology revenue declined due to policy-driven drug discontinuation, but other specialties and international business offset the impact. Expansion projects and integration of new assets remain on track.
Max Healthcare Institute Quarterly report: Q4 2026
Max Healthcare Institute has published its Q4 2026 quarterly earnings report on May 22, 2026.
Max Healthcare Institute Slides: Q4 2026
Max Healthcare Institute has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 22, 2026.
Why are Max Healthcare falling over 6% today? Details here
Shares of Max Healthcare Institute fell more than 6% in early trade on Friday, May 22, after the hospital operator reported its March quarter (Q4 FY26) earnings. As of 9:35…
Top stocks for trade today, May 22: ITC, LIC, GAIL India, Max Healthcare, Paytm, Aurobindo Pharma and more
Indian stock markets are expected to track company earnings, block deal developments, and sector-specific triggers on May 22. Several companies, including ITC Limited, Life Insurance Corporation of In...
Max Healthcare recommends Rs 2 per share dividend for FY26
Max Healthcare Institute's board of directors has approved several key resolutions during its meeting held on 21 May 2026. Among the significant decisions, the board recommended a final dividend of…
Max Healthcare Institute approves ₹2 per share dividend and plans new hospital construction
Max Healthcare Institute has announced a series of significant decisions following its board meeting held on May 21, 2026. Key outcomes include the approval of a final dividend, the re-appointment…
Max Healthcare Institute announces no substantive business updates
Max Healthcare Institute has released a regulatory filing that does not contain any substantive business updates or new information relevant to its operations or financial performance. The document co...
Max Healthcare reports Q4 revenue of ₹2,664 crore with 10% YoY growth
Max Healthcare Institute Ltd., one of India's largest private healthcare service providers, announced robust financial results for the fourth quarter and the fiscal year ending March 31, 2026. The com...
Top stocks to buy today: Stock recommendations for May 21, 2026 - check list
Top stock market recommendations: Aakash K Hindocha, Deputy Vice President - WM Research, Nuvama Professional Clients Group has recommended Varun Beverages, Max Healthcare Institute, and Page Industri...